李氏大藥廠：環境、社會及管治報告2023.pdf

1、2023Environmental,Socialand Governance Report環境、社會及管治報告目錄CONTENTSBoard Statement 董事會聲明3Business Overview 商業概覽5About this Report 關於本報告6Reporting Period 報告期6Reporting Scope and Boundary 滙報範圍及邊界6Reporting Basis and Principles 滙報基礎及原則7Review and Approval 審閱與批核8Information and Feedbacks 反饋意見8ESG Manageme

2、nt Structure ESG管理架構9Stakeholder Engagement 持份者參與12Materiality Assessment 重要性評估14Materiality Matrix 重要性矩陣15Awards and Recognition 獎項及殊榮17Health and Safety 健康與安全17Corporate Social Responsibility 企業社會責任18Operating Practices 營運慣例20Product Responsibility 產品責任22Environmental Protection 環境保護23Environmenta

3、l Policy 環境政策23Emissions 排放24Use of Resources 資源使用29The Environment and Natural Resources 環境及自然資源33Climate Change 氣候變化36Employment and Labour Practices 僱傭和勞工慣例43Employment 僱傭43Health and Safety 健康與安全49Development and Training 發展和培訓52Labour Standards 勞工準則55Operating Practices 營運慣例56Supply Chain Manag

4、ement 供應鏈管理56Product Responsibility 產品責任58Anti-corruption 反貪污61Community Investment 社區投資64Contribution to Different Community Aspects 於不同社區方面的貢獻64Stock Exchanges ESG Reporting Guide Index 聯交所 環境、社會及管治報告指引 內容索引表72GRI Standards Content Index GRI 準則內容索引表80TCFD Content Index 氣候相關財務披露內容索引表93SDGs Content

5、Index 可持續發展目標內容索引表95Environmental,Social and Governance Report 2023 環境、社會及管治報告3Board Statement董事會聲明On behalf of the board(the“Board”)of directors(the“Directors”)of the Lees Pharmaceutical Holdings Limited(the“Company”)and its subsidiaries(collectively,the“Group”or“Lees Pharm”or“we”or“us”),I hereby p

6、resent to you the 2023 Environmental,Social and Governance(“ESG”)Report(this“Report”),providing an overview of the Groups approach,performance and commitment on material corporate sustainability issues that have impacts on our operation.The Group puts the sustainable development of its business as t